Claritev Corporation

NYSE:CTEV

Medical - Healthcare Information Services

Healthcare
$22.30 +1.41%

+$0.42 today

Market cap
$380.77M
Beta
0.77
P/E (TTM)
-1.8
EPS (TTM)
-$17.16
52W Low $11.50High $74.07

Volume 0.31M

Average 0.14M

CTEV Total Equity

Shareholders' claim on the company's assets after all liabilities: total assets minus total liabilities.

Claritev CorporationNYSE: CTEV

Total Equity · Q1 FY2026 · quarter ended Mar 2026

Total equity turns negative

Q1 FY2026 total equity was -$234.41M, compared with $14.83M a year earlier.

Context

  • Total equity amounted to 4.8% of total assets at the end of Q1 FY2026, up 4.6 pp from a year earlier.
  • Total equity increased in 0 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether total equity keeps falling in the next quarterly balance sheet after a -1681.2% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
-$234.41M-40.2% QoQ
Last fiscal yearDec 2025
-$167.18M-299.0% YoY
Year agoMar 2025
$14.83M-1681.2% since
Total Equity past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-1681.2%——
1 year-299.0%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Total Equity history

USD · from the balance sheet

Latest · FY2025
(167.18M) USD
Year-over-year change
-299.0%

Total Equity vs competitors

How CTEV compares with its peers on the latest reported figures

  • CTEV's Mar 2026 total equity of -$234.41M is the lowest of the 11 companies compared; the peer median is $559.04M.
  • Its year-over-year change of -1681.2% is the lowest of 11, against a peer median of +0.9%.
  • Total equity amounts to 4.8% of total assets for CTEV, versus a peer median of 48.4%.
CTEV Competitors Peer median
Total Equity for CTEV and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
OPKOPKO Health, Inc.Mar 2026$1.2B -8.2%-6.7%64.9%
DNTHDianthus Therapeutics, Inc.Jun 2026$1.17B +286.7%+88.5%96.6%
IARTIntegra LifeSciences Holdings CorporationMar 2026$1.04B -31.6%-16.7%29.1%
INMDInMode Ltd.Mar 2026$661.25M +6.8%+7.2%88.1%
GDRXGoodRx Holdings, Inc.Mar 2026$621.99M -4.9%-8.9%30.8%
AXGNAxoGen, Inc.Sep 2026$496.1M +310.7%+8.5%90.1%
EVHEvolent Health, Inc.Mar 2026$396.39M -57.6%-21.5%21.1%
SANASana Biotechnology, Inc.Mar 2026$119.24M -43.0%-31.4%31.9%
IRMDIRadimed CorporationMar 2026$98.51M +9.4%+8.7%86.1%
LFMDLifeMD, Inc.Mar 2026$15.04M +3928.6%—21.4%
CTEVClaritev CorporationMar 2026-$234.41M -1681.2%—4.8%
Peer median (excluding CTEV) $559.04M+0.9%-6.7%48.4%

Competitors are the stored peer set for CTEV. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents185.33M334.05M71.55M16.85M16.81M
Short-term Investments00000
Net Receivables99.91M78.91M84.76M111.61M138.18M
Inventory00000
Other Current Assets4.05M10.19M12.5M19.82M25.86M
Total Current Assets319.26M446.74M193.59M175.52M224.37M
Property, Plant & Equipment (Net)243.34M257.07M287.11M308.75M340.29M
Goodwill4.36B3.71B3.83B2.4B2.41B
Intangible Assets3.29B2.94B2.63B2.23B1.88B
Long-term Investments00015M0
Tax Assets00000
Other Non-current Assets9.7M21.9M21.78M22.1M33.34M
Total Non-current Assets7.9B6.92B6.77B4.98B4.66B
Total Assets8.22B7.37B6.96B5.15B4.89B
Account Payables13.01M13.3M19.59M86.33M60.46M
Short-term Debt13.25M13.25M13.25M13.25M19.4M
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities25.42M34.57M44.72M33.69M181.5M
Total Current Liabilities141.91M175.84M166.74M213.79M261.36M
Long-term Debt4.88B4.74B4.53B4.51B4.6B
Deferred Tax Liabilities753.83M639.5M521.71M325.83M197.6M
Deferred Revenue (Non-current)00000
Other Non-current Liabilities74.14M2.47M17.26M3.6M(16.24M)
Total Non-current Liabilities5.73B5.4B5.09B4.85B4.79B
Total Liabilities5.88B5.58B5.26B5.07B5.06B
Common Stock67K67K2K2K2K
Retained Earnings225.11M(347.8M)(499.31M)(2.15B)(2.43B)
Accumulated OCI00(11.78M)(5.06M)(4.17M)
Other Stockholders Equity00000
Minority Interest00006.73M
Total Equity2.34B1.79B1.71B84.02M(167.18M)
Total Debt4.93B4.78B4.57B4.54B4.63B
Net Debt4.74B4.45B4.5B4.52B4.62B

Claritev Corporation

NYSE:CTEV

Intrinsic Alpha fair value

Locked

Current Price

$22.30

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.